These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16681954)

  • 1. [Neuropsychiatric manifestations in systemic lupus erythematosus and the treatment of intrathecal methotrexate plus dexamethasone].
    Zhou HQ; Leng XM; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):771-4. PubMed ID: 16681954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients.
    Zhou HQ; Zhang FC; Tian XP; Leng XM; Lu JJ; Zhao Y; Tang FL; Zhang X; Zeng XF; Zhang ZL; Zhang W; Dong Y
    Lupus; 2008 Feb; 17(2):93-9. PubMed ID: 18250131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus.
    Dong Y; Zhang X; Tang F; Tian X; Zhao Y; Zhang F
    Chin Med J (Engl); 2001 Jul; 114(7):764-6. PubMed ID: 11780346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
    Wang J; Zhao Y; Zhang J; Lei H; Zhu G; Fu B
    Cell Biochem Biophys; 2014 Nov; 70(2):1005-9. PubMed ID: 24845150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical manifestations, laboratory test, treatment and outcome of neuropsychiatric involvement in pediatric systemic lupus erythematosus patients].
    Wu XY; Song HM; Zeng XF; He YY; Wang W; Li F; Guo YZ; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):286-90. PubMed ID: 19555568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric systemic lupus erythematosus among Nigerians.
    Adelowo OO; Oguntona AS; Ojo O
    Afr J Med Med Sci; 2009 Mar; 38(1):33-8. PubMed ID: 19722426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE.
    Nie Y; Sun B; He X; Zheng M; Wu D; Yang Y; Zhang L; Bai W; Jiang N; Qiao L; Huang C; Zhou S; Zhou J; Peng L; Niu J; Li M; Zhao Y; Zeng X; Wang L; Zhang W
    Arthritis Res Ther; 2023 Mar; 25(1):50. PubMed ID: 36978144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
    Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
    J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J; Krumholz A; Handwerger B
    Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
    Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
    Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echolalia as a novel manifestation of neuropsychiatric systemic lupus erythematosus.
    Zapor M; Murphy FT; Enzenauer R
    South Med J; 2001 Jan; 94(1):70-2. PubMed ID: 11213948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
    Fragoso-Loyo HE; Sánchez-Guerrero J
    J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.